Can mindfulness ease arthritis pain? small study seeks answers
NCT ID NCT06276387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed pilot study tested an 8-week online mindfulness course in 38 people with rheumatoid arthritis. The goal was to see if patients liked the program, what barriers they faced, and how it might affect symptoms. Half the group took the course while the other half received standard care, with results used to plan a larger future study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mindfulness-Based Stress Reduction (MBSR) program
- What this could lead to
- If successful, this could point toward a low-cost, non-drug way to help manage rheumatoid arthritis symptoms and stress.
- What could go wrong
- This is a small pilot study with only 38 participants, so results may not apply widely. It measures satisfaction and feasibility, not proof of symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Osher Center for Integrative Health
San Francisco, California, 94115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell study could pave way for new arthritis treatments
- Are women with autoimmune diseases getting the gynecological care they need?
- Brain scans may predict who gets long-term pain from arthritis
- Can a simple blood test help rheumatoid arthritis patients get the right drug?
- Tiny study peers inside finger joints to unlock RA bone erosion secrets
- Seaweed compound could ease arthritis pain in new trial